Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (231-240 of 300) with videos related to

Pageof 30
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2011
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsGopa Iyer, Michael J Morris, Dana Rathkopf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.
The Lancet. Oncology|June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trialMark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Components of professional competence for nuclear medicine physiciansAbass Alavi, William H Blahd, Sally J DeNardo, et al.
EJNMMI Research|October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancerPhilipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
Annals of Surgical Oncology|April 9, 2011
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysisTobias Leibold, Timothy J Akhurst, David B Chessin, et al.
Pageof 30

Showing results (231-240 of 300) with videos related to

Sort By:
Pageof 30
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2011
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsGopa Iyer, Michael J Morris, Dana Rathkopf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.
The Lancet. Oncology|June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trialMark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Components of professional competence for nuclear medicine physiciansAbass Alavi, William H Blahd, Sally J DeNardo, et al.
EJNMMI Research|October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancerPhilipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
Annals of Surgical Oncology|April 9, 2011
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysisTobias Leibold, Timothy J Akhurst, David B Chessin, et al.
Pageof 30